Abstract
Background
Despite advancements in HIV management, healthcare inequalities continue to exist, especially in rural and populations vulnerable to HIV, where factors such as distance, low income, prejudice, and a shortage of healthcare workers contribute to delayed diagnosis and inadequate care.
Objective
This commentary explores how telemedicine can close the healthcare disparity gap for HIV patients in rural and vulnerable settings by bringing care closer and decreasing stigma.
Methods
The study analyzed primary sources, such as articles from PubMed, Science Direct, the Web of Science, and WHO reports from 2020 to 2024, including case studies, to examine the role of telemedicine in global HIV care. It assessed challenges, effectiveness, and infrastructural barriers, as well as policy implications.
Results
Telemedicine in HIV care for rural and vulnerable groups includes virtual consultation, monitoring, telehealth, digital health education, diagnostic services, telecounselling, telemental health, telepreventive care, and emergency services. It improves treatment involvement, reduces travel, ensures confidentiality, and reduces social disapproval. However, internet inefficiency and infrastructure issues in isolated regions hinder its use.
Conclusion
Telemedicine effectively addresses HIV care gaps in rural and high-risk populations by increasing service utilization, reducing stigma, and improving patient care quality; however, long-term sustainability requires infrastructure improvements and internet connectivity issues.
Keywords: Telemedicine, HIV, Vulnerable communities, Telehealth, Stigma
Even though the treatment of HIV has greatly improved, inequalities still exist, particularly with regard to rural and communities vulnerable to HIV infection. In this commentary, “rural” refers to communities characterized by low population density, limited access to healthcare infrastructure, and significant distances from specialized HIV treatment services. The challenges these groups encounter include geographical proximity, limited socioeconomic status, prejudice and discrimination, a lack of healthcare professionals, and technological difficulties [1]. Remote access results in delayed diagnosis, considerable variation in treatment, and consequently, adverse health effects. Other barriers include failure to access means of transport, a lack of money to pay for services or products, and tight working schedules. Stigma, particularly in rural, tightly knit communities where confidentiality is challenging, prevents patients from seeking healthcare services due to fear of disclosure and social rejection. This fear of being identified as a person living with HIV can result in delayed testing, poor linkage to care, and suboptimal adherence. In such contexts, stigma is a powerful barrier to engagement in HIV prevention, treatment, and support services [2, 3]. Telemedicine can help diminish these effects by providing a private and discreet way for patients to consult healthcare providers from their homes, reducing the chance of unintended disclosure and the accompanying social stigma [4]. However, it is important to consider that while telemedicine enhances privacy for some, home dynamics such as shared living spaces may pose new confidentiality risks. Providers must assess patients’ home environments to ensure telehealth conversations remain private and secure. While patient stigma is a recognized barrier to HIV care, provider stigma must also be addressed to ensure telemedicine solutions are truly equitable and effective. If clinicians hold negative attitudes about people living with HIV, these biases can be transmitted virtually just as easily as in person. Interventions such as provider cultural humility training, inclusive telehealth protocols, and routine measurement of stigma-related attitudes should be incorporated alongside telemedicine rollouts to sustain patient engagement and achieve better outcomes [5]. Virtual visits allow patients to access counseling, follow-up, and medication management without fear of being seen in a local clinic or pharmacy known for HIV services. This privacy protection is particularly crucial for populations vulnerable to discrimination based on their HIV status, sexual orientation, or other marginalized identities [6]. The scarcity of health care providers reduces the quality of the care and support given to patients [5, 7]. As such, these challenges speak to the significance of developing solutions that aim to improve the quality of HIV care. Telemedicine offers a novel opportunity to tackle these disparities by offering clients uninterrupted remote healthcare services as well as minimising the effects of stigma.
The components of telemedicine in HIV care among rural and vulnerable groups include virtual consultation, remote adherence monitoring, telehealth, digital health education, remote diagnostic and laboratory services, tele-counselling/tele-mental health, tele-preventive care, and emergency telehealth. Virtual consultations (via video or telephone) enable patients to connect with HIV specialists for treatment initiation, counseling, and routine follow-up. Remote adherence monitoring uses mHealth apps, medication dispenser boxes, or text-based reminders to support treatment compliance. Digital health education involves web-based training materials, virtual health promotion programs, and online resources to build HIV knowledge and self-management skills. Additionally, remote diagnostic services, including home-based specimen collection and mobile clinic-based laboratory testing, support ongoing clinical monitoring. Moreover, tele-support services, such as online peer counseling and moderated support groups, offer psychosocial assistance and community connection. Lastly, emergency telehealth hotlines provide rapid response and triage during urgent care episodes. Structuring telemedicine services in this way provides a more integrated and logical foundation for HIV service delivery in rural and vulnerable populations [8, 9].
By embracing telemedicine modalities, individuals vulnerable to HIV may be more willing to engage in care because these platforms reduce their exposure to stigma-related fears. Privacy during virtual consultations can protect patients from being labeled or judged within their communities, fostering stronger engagement with care routines, adherence to antiretroviral therapy, and consistent provider communication. However, willingness is also shaped by personal beliefs, past experiences, and perceived trust in digital systems [1, 10].
Telemedicine has now become a vital and indispensable tool within the HIV care continuum, well established to improve outcomes in chronic disease management, including HIV. Rather than being a one-time milestone, telemedicine should be considered a sustainable and integral part of ongoing HIV care strategies, ensuring patients can reliably access services regardless of location or stigma-related barriers. The rapid development of digital health innovations and the growing trends in telemedicine offer a favorable chance to introduce telemedicine as an integral component of HIV treatment. Telemedicine enables patients in remote and rural areas to receive specialised treatment without the need for long-distance travel or proximity to health facilities. Scheduled interactions with physicians keep clients engaged and in check with the proper management of HIV. Additionally, telemedicine provides privacy, eliminating the risk of stigmatization, unlike in-person clinic visits [11]. In general, telemedicine has the potential to improve resource efficiency by reducing travel costs, time away from work, and transportation burdens for patients. However, evidence on overall cost-effectiveness remains mixed, since investments in infrastructure, training, and sustained program support are also required to make telemedicine scalable and equitable [11]. Beyond internet connectivity and infrastructure barriers, several additional challenges limit the effectiveness and scalability of telemedicine in HIV care. Digital literacy gaps, especially among older adults, individuals with limited education, and low-income populations, may prevent them from effectively navigating telehealth systems and engaging fully in remote care. Moreover, regulatory issues such as cross-jurisdictional provider licensing and inconsistent reimbursement frameworks can create obstacles to broad implementation, particularly when patients move between health systems or regions. Additionally, routine in-person laboratory monitoring remains essential to assess viral suppression, monitor drug side effects, and support comprehensive clinical evaluation, which telemedicine alone cannot replace. Addressing these critical challenges requires hybrid care models, coordinated policy changes, and targeted education programs for both patients and providers to maximize the benefits of telemedicine [8, 9].
The COVID-19 pandemic created an unprecedented opportunity to accelerate the adoption of telemedicine for HIV care globally. Lockdown restrictions and social distancing forced health systems to adapt quickly, demonstrating how virtual care platforms could maintain continuity of antiretroviral therapy, counseling, and prevention services even during emergencies [12]. Programs like Project Extension for Community Healthcare Outcomes (ECHO) and Academic Model Providing Access to Healthcare (AMPATH) successfully leveraged virtual mentorship, provider training, and patient outreach to expand HIV services in resource-limited settings during the pandemic, offering valuable lessons for sustaining telemedicine innovations beyond COVID-19 [13, 14]. These experiences illustrate that integrating telemedicine into routine HIV care is not only feasible but also essential for resilient, adaptable healthcare delivery in the face of future public health crises [8, 15].
Telemedicine has effectively enhanced HIV prevention and increased pre-exposure prophylaxis (PrEP) use among groups vulnerable to HIV infection, particularly among young black and Hispanic men who have sex with men [16]. Lawal et al. [15] conducted a study assessing the efficacy of traditional face-to-face and telemedicine methods for managing HIV in rural Georgia, concluding that telemedicine can provide HIV care that is comparable to traditional models, especially in rural regions with restricted access to specialized healthcare services. A comparable study in Georgia demonstrated that the establishment of a comprehensive HIV telehealth infrastructure has enhanced care accessibility in underprivileged regions, leading to elevated rates of viral suppression among patients using telemedicine services [17]. Nonetheless, obstacles persist, such as the integration of electronic health records, privacy issues, and insufficient digital access for certain rural patients [17]. Notwithstanding these challenges, telemedicine demonstrates promise for enhancing HIV care and attaining control in remote areas [15]. Furthermore, the innovative applications of telemedicine are threatened by several issues in rural areas that consist of high-speed internet connectivity and adequate modality. While telemedicine can improve access and continuity of HIV care, it cannot entirely replace the need for periodic laboratory testing required for monitoring HIV viral load, CD4 counts, and drug toxicity. For patients engaging in telemedicine, hybrid care models should be implemented, combining virtual visits with scheduled in-person laboratory testing at community-based clinics or partnering laboratories. Additionally, innovations such as home-based self-sampling kits, community mobile phlebotomy services, or sample pick-up programs can help ensure that critical laboratory monitoring is performed in a timely manner [18]. These strategies are vital to maintain treatment quality and to meet clinical guidelines while maximizing the convenience and privacy benefits of telemedicine.
Although telemedicine is sometimes viewed as a complementary strategy to traditional in-person care, there is growing evidence that telemedicine must become an integral and routine part of HIV care delivery. For patients in rural and socially complex settings, traditional in-person models alone cannot consistently ensure access, continuity, and adherence, given persistent barriers such as stigma, travel distance, and provider shortages. Telemedicine is not optional; it is increasingly essential to achieving equitable HIV care. Without incorporating telemedicine into routine services, health systems will continue to leave these populations behind. Case studies from Georgia and other underserved regions demonstrate that telemedicine-supported models improve viral suppression rates, enhance PrEP uptake, and support ongoing care engagement, outcomes that traditional models alone often fail to achieve. These examples make clear that integrating telemedicine is not simply an enhancement, it is a requirement to meet the needs of vulnerable populations. To boost telemedicine use, there is need to increase the telemedicine infrastructure, increase the training and education of healthcare providers and patients, and continuous research of telemedicine in HIV care is essential. The availability of internet connections, cheap and effective devices, and technical assistance are vital for the expansion and sustainability of telemedicine services. Thus, telemedicine has great potential to improve HIV care, especially for rural and populations vulnerable to HIV infection. Therefore, if the barriers to telemedicine are addressed, telemedicine can serve as an indispensable component of effective HIV care, integrated routinely into service delivery rather than viewed as a temporary milestone. Its potential to enhance access, adherence, and some HIV-related outcomes makes telemedicine a valuable tool within HIV care. However, more rigorous evaluation of its long-term effects and cost-effectiveness is needed [8]. In addition to general benefits, specific strategies that could strengthen telemedicine’s impact for vulnerable populations have been documented in the literature. For example, integrating telemedicine with community health worker outreach has been shown to build trust and bridge digital divides among rural patients [15]. Another approach is to include tele-mental health components within HIV telemedicine platforms to address co-occurring mental health challenges, which are common in people living with HIV [16, 19]. Scheduled virtual adherence counseling and the use of SMS-based reminders can also help sustain treatment engagement and minimize missed appointments [8]. These concrete, evidence-based strategies highlight how telemedicine can be tailored to the complex needs of rural and vulnerable populations.
In conclusion, telemedicine should be fully integrated into routine HIV care, particularly for vulnerable and geographically isolated populations rather than viewed as an optional or complementary service. Its capacity to enhance access, maintain confidentiality, reduce stigma, and support adherence makes it indispensable for achieving high-quality, equitable care for populations affected by HIV. Building on lessons from COVID-19 and global digital health initiatives, policymakers and providers must invest in telemedicine infrastructure, regulatory harmonization, and workforce training to deliver equitable and sustainable HIV services for all. Thus, health systems can ensure no patient is excluded, regardless of geographic, social, or economic circumstances.
Acknowledgements
Not applicable.
Author contributions
Author contributionsConceptualization: COE, EUAMethodology: EUA, OPCUResources: COE, OPCUSupervision: OPCU Validation: COEVisualization: EUA Writing– original draft: EUAWriting– review & editing: COE, EUA, OPCU.All Authors reviewed and approved the manuscript for publication.
Funding
No funding was received.
Data availability
No datasets were generated or analysed during the current study.
Declarations
Consent for publication
All Authors read and approved the manuscript for publication.
Competing interests
The authors declare no competing interests.
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Footnotes
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Bouabida K, Chaves BG, Anane E. Challenges and barriers to HIV care engagement and care cascade: viewpoint. Front Reprod Health. 2023;5:1201087. 10.3389/frph.2023.1201087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Obeagu E, Obeagu G, Odo E, Igwe M, Paul-Chima O, Alum PCU, Okwaja E, Extension P. Combatting stigma: essential steps in halting HIV spread. IAA J Appl Sci. 2024;11:22–9. [Google Scholar]
- 3.Babel RA, Wang P, Alessi EJ, Raymond HF, Wei C. Stigma, HIV risk, and access to HIV prevention and treatment services among men who have sex with men (MSM) in the united states: A scoping review. AIDS Behav. 2021;25:3574–604. 10.1007/s10461-021-03262-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ezenwaji CO, Alum EU, Ugwu OP-C. The role of digital health in pandemic preparedness and response: Securing global health? Global Health Action. 2024;17:2419694. 10.1080/16549716.2024.2419694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Shahmanesh M, Chimbindi N, Busang J, Chidumwa G, Mthiyani N, Herbst C, Okesola N, Dreyer J, Zuma T, Luthuli M, Gumede D, Hlongwane S, Mdluli S, Msane S, Smit T, Molina J-M, Khoza T, Behuhuma NO, McGrath N, Seeley J, Harling G, Sherr L, Copas A, Baisley K. Effectiveness of integrating HIV prevention within sexual reproductive health services with or without peer support among adolescents and young adults in rural KwaZulu-Natal, South Africa (Isisekelo Sempilo): 2 × 2 factorial, open-label, randomised controlled trial. Lancet HIV. 2024;11:e449–60. 10.1016/S2352-3018(24)00119-X. [DOI] [PubMed] [Google Scholar]
- 6.Smith E, Badowski ME. Telemedicine for HIV care: current status and future prospects. HIV AIDS (Auckl). 2021;13:651–6. 10.2147/HIV.S277893. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Simon M, Derrick S, Kosanam S, Pasupula R. Pill burden: A major barrier to HAART adherence and fixed dose combinations (FDCS) as its Solution - A Mini-Review. Curr HIV Res. 2024. 10.2174/011570162X307740240604115154. [DOI] [PubMed] [Google Scholar]
- 8.Cuadros DF, Huang Q, Mathenjwa T, Gareta D, Devi C, Musuka G. Unlocking the potential of telehealth in Africa for HIV: opportunities, challenges, and pathways to equitable healthcare delivery. Front Digit Health. 2024;6:1278223. 10.3389/fdgth.2024.1278223. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Haleem A, Javaid M, Singh RP, Suman R. Telemedicine for healthcare: capabilities, features, barriers, and applications. Sens Int. 2021;2:100117. 10.1016/j.sintl.2021.100117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Campbell K, Greenfield G, Li E, O’Brien N, Hayhoe B, Beaney T, Majeed A, Neves AL. The impact of virtual consultations on the quality of primary care: systematic review. J Med Internet Res. 2023;25. 10.2196/48920. [DOI] [PMC free article] [PubMed]
- 11.Stoltzfus M, Kaur A, Chawla A, Gupta V, Anamika FNU, Jain R. The role of telemedicine in healthcare: an overview and update. Egypt J Intern Med. 2023;35:49. 10.1186/s43162-023-00234-z. [Google Scholar]
- 12.Aloh HE, Asadu N, Ogbuke MU, Mezieobi KC, Agboti CI, Agu PC, Uti DE, Alum EU. Lesson from COVID-19: rethinking urban planning for future health emergencies-Uganda in focus. J Urban Manage. 2025. 10.1016/j.jum.2025.05.005. [Google Scholar]
- 13.Atuhairwe I, Ngabirano AA, Ahaisibwe B, Nsubuga A, Kanyike AM, Kihumuro RB, Balizzakiwa T, Ewing H, Ellis R, Forbush L, Joseph O, Nakyeyune MJ, Waniaye JB. Leveraging tele-mentoring and remote learning to strengthen the emergency care capacity of health workers in Uganda. Afr J Emerg Med. 2023;13:86–93. 10.1016/j.afjem.2023.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Mubanga B, Fwoloshi S, Lwatula L, Siamwanza N, Zyambo K, Sichinga H, Tappis H, Mulenga LB, Moonga A, Ziko L, Simushi F, Massamba HM, Hapunda G, Sichimba F, Mtonga H, Kalubula M. Effects of the ECHO tele-mentoring program on HIV/TB service delivery in health facilities in zambia: a mixed-methods, retrospective program evaluation. Hum Resour Health. 2023;21:24. 10.1186/s12960-023-00806-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Lawal FJ, Rao ASRS, Vazquez JA. 1010. Effective management of HIV in rural Georgia using telemedicine. Open Forum Infect Dis. 2020;7. 10.1093/ofid/ofaa439.1196.
- 16.Wong KYK, Stafylis C, Klausner JD. Telemedicine: a solution to disparities in human immunodeficiency virus prevention and pre-exposure prophylaxis uptake, and a framework to scalability and equity. mHealth. 2020;6. 10.21037/mhealth.2019.12.06. [DOI] [PMC free article] [PubMed]
- 17.Salgado S, Felzien G, Brumbeloe J. Georgia leverages telehealth to expand HIV care management in underserved areas. Am J Prev Med. 2021;61:S55–9. 10.1016/j.amepre.2021.07.001. [DOI] [PubMed] [Google Scholar]
- 18.Madu CV, Alum EU, Aloh HE, Ugwu OPC, Obeagu EI, Uti DE, Egba SI, Ukaidi CUA, Alum NB. The price of progress: assessing the financial costs of HIV/AIDS management in East Africa. Med (Baltim). 2025;104. 10.1097/MD.0000000000042300. e42300. [DOI] [PMC free article] [PubMed]
- 19.Alum EU, Obeagu EI, Ugwu OPC, Samson AO, Adepoju AO, Amusa MO. Inclusion of nutritional counseling and mental health services in HIV/AIDS management: A paradigm shift. Medicine. 2023;102:e35673. 10.1097/MD.0000000000035673. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
No datasets were generated or analysed during the current study.
